President Donald Trump has said it plainly: Americans pay “massively higher prices than other nations pay for the same exact pill, from the same factory.” 

He’s right, and unlike many politicians before him, he forced the pharmaceutical industry to the table. TrumpRx and his Most Favored Nation pricing agreements achieved something Washington insiders long insisted was impossible: They created real pressure on drugmakers to lower prices for American patients.